O & P Clinical Technologies is categorized under Artificial Limbs in Gainesville, FL .
O & P Clinical Technologies was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Artificial Limbs business, which does work in the B2C market, and is classified as a Artificial Limbs, under code number 4461990 by the NAICS.
If you are seeking more information, feel free to contact Paul Prusakowski, Owner at the company’s single location by writing to 6800 Nw 9th Boulevard # 3, Gainesville, Florida FL 32605 or by phoning (352) 332-5278. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | O & P Clinical Technologies |
| Contact Person: | Paul Prusakowski, Owner |
| Address: | 6800 Nw 9th Boulevard # 3, Gainesville, Florida 32605 |
| Phone Number: | (352) 332-5278 |
| Website Address: | oandp.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Artificial Limbs |
| SIC Code: | 5999 |
| NAICS Code: | 4461990 |
| Share This Business: |
O & P Clinical Technologies was started in 0 to provide professional Artificial Limbs under the SIC code 5999 and NAICS code 4461990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Paul Prusakowski, Owner for inquiries that concern O & P Clinical Technologies by calling the company number (352) 332-5278, as your correspondence is most welcome. Additionally, the physical location of the single location of O & P Clinical Technologies can be found at the coordinates 29.66167,-82.41492 as well as the street address 6800 Nw 9th Boulevard # 3 in Gainesville, Florida 32605.
For its online presence, you may visit O & P Clinical Technologies’s website at oandp.com and engage with its social media outlets through on Twitter and on Facebook.